Schorno Dean L
- SEC CIK
- 0001509688
No open-market purchases or sales filed in the past year.
Current role at each company
- RIGL Rigel Pharmaceuticals IncEVP & Chief Financial Officeras of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schorno Dean L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 (view filing) | Feb 4-5 | 2 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −3.77K | $21.38 | −$80.6K | −6.2%57.2K after | 2 lots |
| Feb 6, 2024 (view filing) | Feb 2-5 | 4 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −12.6K | $1.14 | −$14.3K | −3.0%402.9K after | 2 lots |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −5.39K | $1.66 | −$8.95K | −2.7%196.5K after |